Compounds > uk 21
Page last updated: 2024-09-03

uk 21 and uridine

uk 21 has been researched along with uridine in 5 studies

Compound Research Comparison

Studies
(uk 21)		Trials
(uk 21)		Recent Studies (post-2010)
(uk 21)		Studies
(uridine)		Trials
(uridine)		Recent Studies (post-2010) (uridine)
50012,749691,083

Protein Interaction Comparison

ProteinTaxonomyuk 21 (IC50)uridine (IC50)
Sodium/nucleoside cotransporter 1Homo sapiens (human)5.8
Solute carrier family 28 member 3Homo sapiens (human)5.4

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, T; Kitaichi, K; Koda, A; Mori, H; Sakamoto, O1
Kaku, Y; Kita, J; Koda, A; Maeda, D; Mori, H; Nagai, H; Nakayama, K1
Kitaichi, K; Koda, A; Mori, H; Sakamoto, O1
Abe, K; Hanafi, M; Shibata, K; Tanaka, T; Taniguchi, M; Ueki, M1
Ishida, R; Ito, S; Koda, A; Mori, H; Nagai, H; Nakayama, K1

Other Studies

5 other study(ies) available for uk 21 and uridine

ArticleYear
Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
    Japanese journal of pharmacology, 1992, Volume: 59, Issue:4

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Fluorouracil; Glycine; Leukemia L1210; Leukemia P388; Lung Neoplasms; Methylcholanthrene; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Neoplasms, Experimental; Organ Size; Sarcoma 180; Spleen; Tegafur; Thymus Gland; Uridine

1992
Novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21: antitumor activity and effect on humoral immune response in mice.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:3

    Topics: Analysis of Variance; Animals; Antibody Formation; Antineoplastic Agents; Carcinoma; Female; Glycine; Immunosuppressive Agents; Leukemia, Experimental; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Uridine

1994
Novel low immunosuppressive derivatives of the antitumor drug fluoropyrimidine, UK-21 and UK-25: effect on delayed type hypersensitivity and tumor immunity.
    Japanese journal of pharmacology, 1993, Volume: 61, Issue:3

    Topics: Animals; Antineoplastic Agents; Erythrocytes; Female; Fluorouracil; Glycine; Hypersensitivity, Delayed; Immunity; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Sheep; Spleen; Uridine

1993
UK-2A, B, C and D, novel antifungal antibiotics from Streptomyces sp. 517-02. I. Fermentation, isolation, and biological properties.
    The Journal of antibiotics, 1996, Volume: 49, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Antifungal Agents; Cell Division; Fermentation; Glycine; Humans; Lactones; Mice; Microbial Sensitivity Tests; Oxygen Consumption; Pyridines; Saccharomyces cerevisiae; Streptomyces; Tumor Cells, Cultured; Uridine

1996
Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21.
    Anti-cancer drugs, 1997, Volume: 8, Issue:5

    Topics: Antimetabolites, Antineoplastic; Cell Cycle; Cell Survival; Flow Cytometry; Floxuridine; Fluorouracil; Glycine; Humans; Immunosuppressive Agents; KB Cells; Neoplastic Stem Cells; Thymidine; Uridine

1997